Female voiding dysfunction and incontinence are common in the general population and symptoms have been shown to have a significant negative impact on health-related quality of life. This article highlights the epidemiology, evaluation, diagnosis, pharmacologic therapies, and surgical treatment for overactive bladder, stress urinary incontinence, and urogenital fistulas.
- Overactive bladder (OAB)
- Stress urinary incontinence (SUI)
- Ureterovaginal fistula (UVF)
- Urge urinary incontinence (UUI)
- Vesicovaginal fistula (VVF)
ASJC Scopus subject areas